U.S. Industrials Stock News

Sensient Technologies Corporation recently reported past second-quarter 2026 results showing higher sales of US$462.08 million and net income of US$51.36 million, alongside raised full-year 2026 diluted EPS guidance to a range of US$4.10–US$4.20. The company’s stronger earnings and increased guidance were accompanied by an affirmed quarterly dividend of US$0.41 per share, underscoring ongoing capital returns to shareholders. Next, we will examine how Sensient’s upgraded earnings guidance...

In July 2026, Kate Farms, Inc. reported that its High Protein Nutrition Shake would be available in more than 6,800 Walmart and CVS Health stores nationwide following continued retail expansion and a recent CVS launch. Earlier in July, CVS Health also opened new smaller, pharmacy-focused locations, underscoring a push to refine its retail footprint and emphasize in-person pharmacy care across diverse communities. Now, we’ll consider how CVS’s rollout of smaller, pharmacy-focused locations...

Vishay Precision Group stock has delivered a very strong 262.2% return over the past year, yet the valuation picture is mixed because the Discounted Cash Flow (DCF) intrinsic value estimate points to a sizeable discount while traditional market multiples suggest the shares are expensive. The 262.2% one year return sets high expectations for what Vishay Precision Group needs to deliver to justify the current share price. Future cash flow growth and margin durability can support the DCF view...

Why H.B. Fuller’s refinancing move matters for stock watchers H.B. Fuller (FUL) recently overhauled key debt facilities, refinancing $420 million in term loans, expanding its revolving credit capacity, extending maturities to 2031 and trimming interest margins, a balance sheet shift investors are now assessing. See our latest analysis for H.B. Fuller. Despite the refinancing and a recent dividend affirmation, H.B. Fuller’s share price has been under pressure, with a 30 day share price return...

DoorDash stock has delivered a strong 103.1% gain over the past three years, yet its valuation checks currently point to a company that screens as expensive rather than a clear bargain. DoorDash has returned 103.1% over three years, which sets a high bar for any further upside to be justified by fundamentals. Efforts to roll out autonomous delivery robots and expand AI driven customer support may support growth expectations, while heavy investment requirements and execution risks in these...

Analog Devices stock has delivered a strong 141.5% total return over the past 5 years, yet the latest valuation checks suggest the shares now lean expensive rather than clearly cheap. A 141.5% return over 5 years highlights how strongly Analog Devices has rewarded long term shareholders, which raises the bar for any new upside from here. Investor focus on cash generation across the sector, illustrated by Texas Instruments planning lower capital spending to support free cash flow, can support...

NiSource (NI) continues to attract attention from investors focusing on regulated utilities after a period of mixed share performance. The stock is down about 6.7% over the past month and roughly 5.5% over the past 3 months. See our latest analysis for NiSource. Over a longer horizon NiSource has delivered an 8.66% year to date share price return and a 13.97% total shareholder return over the past year. However, recent one month trading momentum has softened as the stock adjusts to shifting...

Nasdaq, Inc. recently reported second-quarter 2026 results showing revenue of US$1,500 million and net income of US$507 million, alongside confirming a quarterly dividend of US$0.3100 per share payable on September 25, 2026, and updating investors on the completion of a long-running share repurchase program initiated in 2014. At the same time, the dismissal with prejudice of a long-running patent dispute with Miami International Holdings removes a legal overhang and allows both sides to...

Boston Scientific has issued a voluntary Class II recall of its Rapid Refill Continuous Injection System. The recall is linked to a risk that syringes may loosen or detach, which could affect device performance and procedural outcomes. The action covers a large number of units distributed in the US and international markets. For investors watching Boston Scientific, ticker NYSE:BSX, this recall comes amid a mixed share performance backdrop. The stock closed at $45.51, with returns up 4.0%...

In the lead-up to its early August 2026 earnings release, Supernus Pharmaceuticals attracted attention after analysts highlighted its positive Earnings ESP and prior earnings outperformance. This heightened optimism around another potential earnings beat has sharpened focus on whether the company’s recent execution can support its longer-term CNS growth ambitions. With analysts pointing to a positive Earnings ESP as a key signal, we’ll now examine how this shapes Supernus Pharmaceuticals’...

What triggered the latest move in WEX stock WEX (WEX) drew fresh attention after reporting second quarter 2026 results, issuing new third quarter guidance and raising full year revenue expectations, alongside progress on share buybacks and a new Bluon partnership. See our latest analysis for WEX. The recent guidance upgrade and Bluon agreement appear to have shifted sentiment toward WEX, with a 30 day share price return of 28.96% and year to date share price return of 19.94%. However, the 5...

Rising headlines around renewed US support for Ukraine and possible new weapons agreements are putting fresh attention on defense and aerospace stocks. Changes in military aid, missile production licenses and sanctions talk can quickly reshape where capital flows next. For investors, this theme is less about guessing politics and more about understanding which companies sit closest to the key programs and contracts in focus. This article walks through 3 stocks from the Defense and Aerospace...

Jazz Pharmaceuticals recently reported that analysts had expected a very large year-over-year earnings increase to US$6.04 per share on revenues of about US$1.11 billion for the June 2026 quarter, alongside receiving a second consecutive Gold Stevie Award for Employer of the Year in the pharmaceutical industry. This combination of anticipated earnings strength and external recognition for workplace quality highlights both operational momentum and a culture that may support longer-term...

Dividend announcement puts Helmerich & Payne in focus Helmerich & Payne (HP) has come onto investor radars after announcing a cash dividend of $0.25 per share, alongside continued investment in digitalization and automation of its drilling operations. The dividend decision, combined with commentary that the stock may trade below some intrinsic value estimates, is prompting closer attention to how these technology initiatives could influence the company’s future revenue mix and margin...

Tompkins Financial (TMP) has drawn fresh attention after reporting higher second quarter net interest income and net income, along with a larger quarterly dividend, prompting investors to reassess the stock’s current valuation and income profile. See our latest analysis for Tompkins Financial. The latest earnings, dividend increase and recent share repurchases sit against a strong share price run. Tompkins Financial’s share price return of 16.5% over 90 days and 37.5% year to date, together...

Recently, analysts signaled that Clorox is expected to report June-quarter earnings of US$1.64 per share, a year-over-year decline of 42.9%, on revenues of US$1.91 billion, down 4.1%, with limited indications of an earnings beat. This sharp expected earnings decline, combined with a weak Earnings ESP and Zacks Rank of 4, highlights growing skepticism around the strength of Clorox’s near-term profit trajectory ahead of its August 3 earnings call. Against this backdrop of anticipated earnings...

Assurant (AIZ) drew fresh attention after appointing Kelli Ertel as Chief Communications Officer and Chief of Staff on July 23, 2026. This move adds communications and brand leadership to her existing responsibilities. See our latest analysis for Assurant. Set against this leadership change, Assurant’s share price has climbed 17.6% over the past 90 days and its 1 year total shareholder return stands at 52.1%, which indicates that positive momentum has been building. If this kind of move has...

Welltower (WELL) is back in focus after its Board of Directors declared a quarterly cash dividend of $0.85 per share, coinciding with fresh second quarter 2026 earnings and updated full year guidance. See our latest analysis for Welltower. Alongside the higher dividend, Welltower’s recent earnings beat and slightly lower full year guidance have arrived during a strong run. The stock has posted a 30 day share price return of 9.24% and a 1 year total shareholder return of 59.30%, which suggests...

Plexus (NASDAQ: PLXS) is set to report its latest quarterly earnings after the bell, following a prior quarter in which it exceeded analysts’ revenue estimates and delivered significant year-on-year revenue growth. With the market now expecting more than 21% year-on-year revenue growth this quarter, investor attention is increasingly focused on whether Plexus can maintain its recent revenue momentum. We’ll explore how these heightened expectations for strong year-on-year revenue growth may...

In the second quarter of 2026, SL Green Realty Corp. reported higher revenue of US$264.00 million but a wider net loss of US$20.51 million, while also continuing share repurchases under its long-running buyback program. Alongside the earnings release, SL Green highlighted Manhattan office occupancy of 94.7% with 53 new leases and advanced its SUMMIT observatory brand into Tokyo, underscoring how leasing progress and experiential assets are shaping its office-focused REIT model. We’ll now...

Southside Bancshares, Inc. recently reported past second-quarter and first-half 2026 results showing higher net interest income and net income year-on-year, while also completing a US$35.36 million share repurchase program totaling 1,237,865 shares announced in July 2023. The combination of earnings growth and a fully executed buyback points to management’s focus on profitability and disciplined capital deployment, supported by lower net charge-offs of US$0.3 million in the quarter. With...

McCormick & Company has been celebrating its 2026 Flavor of the Year, Black Currant, through past limited-edition collaborations with Prince St. Pizza and Go Greek Yogurt, featuring dessert pizza and probiotic-rich frozen yogurt that showcase its Sweet & Smoky Black Currant Seasoning and Black Currant Finishing Sugar. By extending Black Currant beyond the spice aisle into branded food-service and frozen yogurt offerings, McCormick is testing how its flavor insights can translate into wider...

Why First Hawaiian stock is in focus after the latest earnings First Hawaiian (FHB) has come back into the spotlight after reporting second quarter 2026 earnings, confirming its quarterly cash dividend, and updating investors on loan charge offs and share repurchases. See our latest analysis for First Hawaiian. First Hawaiian shares trade at US$27.79 after a recent short term pullback, with the 30 day share price return down 5.96% and the 1 year total shareholder return at 15.25%. The 3 year...

Earlier in 2026, SELLAS Life Sciences Group’s CEO Angelos Stergiou underscored how AI and precision medicine could speed drug development and refine patient selection as the company nears a pivotal Phase 3 readout for its acute myeloid leukemia therapy. The remarks, combined with shifting institutional positioning and retail focus on potential partnerships or acquisitions following updated change-of-control terms, have sharpened attention on SELLAS’s future direction. We will now examine how...